²é¿´: 3020  |  »Ø¸´: 18
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÑÛœI³ÉÔŠ

гæ (СÓÐÃûÆø)

[ÇóÖú] ÂÛÎÄÕªÒª£¬ÒѾ­google·­Ò룬Çë¸ßÈ˰ïæÐÞ¸ÄÈóÉ«£¬²»Ê¤¸Ð¼¤

ÖÐÎÄÕªÒª£º
±¾ÎĵÄʵÑéÄ¿µÄ£º£¨1£©¿¼²ìÓ°Ïì·Ç°ÐÏòÐÔ¾ÛÈéËᣨPLA£©ÔØÒ©ÄÉÃ×Á£ÖƱ¸µÄ¹¤ÒÕÒòËØ£¬²¢¶Ô´¦·½½øÐй¤ÒÕÓÅ»¯£¬ÖƱ¸³öÁ£¾¶½ÏС¡¢ÔØÒ©ÂʺͰü·âÂʽϸߵÄPLAÔØÒ©ÄÉÃ×Á££»£¨2£©Ì½Ë÷²»Í¬·´Ó¦Ìõ¼þ¶Ô·Î°ÐÏòÅäÌå·Ö×ÓÒ¶ËᣨFA£©ºÍ͸Ã÷ÖÊËᣨHA£©Å¼ÁªÁ¿µÄÓ°Ï죬ȷ¶¨ÅäÌå·Ö×ÓµÄ×î¼ÑżÁª¹¤ÒÕ£»£¨3£©Í¨¹ýÄ£ÄâÌåÄÚ»·¾³¿¼²ì²»Í¬ÒòËØ¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄܵÄÓ°Ï죬·ÖÎöÊÍÒ©»úÀí²¢½¨Á¢ºÏÊʵÄÊÍÒ©Ä£ÐÍ£¬ÎªÒ©ÎïÔÚÌåÄÚµÄҩЧѧÑо¿µì¶¨»ù´¡¡£²ÉÓõÄʵÑé·½·¨£º£¨1£©²ÉÓø´Èé·¨£¨W/O/W£©ºÍÈ黯ÈܼÁ»Ó·¢·¨£¨O/W£©·Ö±ðÖÆ±¸°ÂɳÀû²¬PLAÄÉÃ×Á£¡¢¼ªÎ÷Ëû±õPLAÄÉÃ×Á£ºÍ×Ïɼ´¼PLAÄÉÃ×Á££¬¶ÔÁ½ÖÖÖÆ±¸·½·¨ÖÐÓ°ÏìÄÉÃ×Á£Á£¾¶ºÍÔØÒ©ÂʵÄÒòËØ½øÐе¥ÒòËØ¿¼²ì£¬É¸Ñ¡³ö½ÏºÃµÄˮƽÉè¼ÆÕý½»ÊµÑ飬ÓÅ»¯µÃµ½×î¼ÑÖÆ±¸¹¤ÒÕ¡£Í¨¹ý͸Éäµç×ÓÏÔ΢¾µ£¨TEM£©ºÍZetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǶÔÄÉÃ×Á£ÐÎòºÍÁ£¾¶½øÐбíÕ÷£»£¨2£©¹ýõ£°·»¯·´Ó¦·Ö±ð½«FAºÍHAżÁªµ½PLAÔØÒ©ÄÉÃ×Á£±íÃæ£¬¿¼²ì²»Í¬·´Ó¦Ìõ¼þ¶ÔÅäÌåżÁªÁ¿µÄÓ°Ïì²¢ÕÒ³ö×î¼ÑżÁª¹¤ÒÕ¡£ºìÍâ¹âÆ×£¨IR£©±íÕ÷ÅäÌåżÁªÇé¿ö£¬Zetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǺÍɨÃèµç×ÓÏÔ΢¾µ£¨SEM£©¶ÔżÁªÅäÌåºóµÄÄÉÃ×Á£Á£¾¶ºÍÐÎò½øÐбíÕ÷£»£¨3£©¿¼²ì²»Í¬PHÖµ£¨PH=4.3¡¢PH=5.6ºÍPH=7.4£©¡¢²»Í¬ÔØÒ©ÂÊ£¨9.53%¡¢17.48%ºÍ26.37%£©ÒÔ¼°Å¼ÁªÅäÌå¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄܵÄÓ°Ï죬²¢Ä£ÄâÈËÌåÄÚ²¿»·¾³½øÐÐÊÍÒ©ÐÐΪµÄÑо¿£¬·ÖÎöÿ¸ö½×¶ÎµÄÊÍÒ©»úÀí£¬ÄâºÏÎåÖÖ³£¼ûÒ©ÎïÄ£Ð͵ÄÇúÏß·½³Ì²¢Ñ¡Ôñ×î¼ÑÊÍÒ©Ä£ÐÍ¡£ÊµÑé½á¹û£º£¨1£©Í¨¹ýµ¥ÒòËØ¿¼²ìºÍÕý½»ÊÔÑéÉè¼ÆÈ·¶¨ÁËÖÆ±¸ÈýÖÖÔØÒ©ÄÉÃ×Á£µÄ×î¼ÑÖÆ±¸¹¤ÒÕ£¬ÔÚ×î¼ÑÖÆ±¸Ìõ¼þÏÂÖÆµÃµÄÔØÒ©ÄÉÃ×Á£ÔØÒ©ÂʺͰü·âÂÊ·Ö±ðΪ26.9%£¬66.5%£»27.4%£¬67.2%ºÍ30.3%£¬73.6%¡£ÄÉÃ×Á£±íÃæ¹â»¬Ô²Õû¡¢·ÖÉ¢ÐԺã¬Æ½¾ùÁ£¾¶·Ö±ðΪ110nm¡¢117nmºÍ125nm£¬ÇÒÁ£¾¶·Ö²¼·¶Î§½ÏÕ­£»£¨2£©ÓúìÍâ¹âÆ×£¨IR£©±íÕ÷ÄÉÃ×Á£±íÃæ·Ö×Ó»ùÍŵı仯£¬±íÃ÷FAºÍHA·Ö±ðͨ¹ýõ£°·¼ü×÷Óóɹ¦µÄżÁªµ½ÁËÄÉÃ×Á£±íÃæ¡£È·¶¨ÁËFAºÍHAµÄ×î¼ÑżÁª¹¤ÒÕ£¬ÔÚ×î¼ÑżÁª·´Ó¦Ìõ¼þÏÂFAºÍHAµÄżÁªÁ¿·Ö±ðΪ0.0237¡Á10-3mol/gºÍ0.0178¡Á10-6mol/g¡£Á£¾¶·ÖÎö±íÃ÷FAżÁªÇ°ºóÄÉÃ×Á£Á£¾¶»ù±¾Îޱ仯£¬HA£¨Mr=300000£©Å¼ÁªºóÁ£¾¶ÓÉ122.2nmÔö³¤µ½131.3nm£¬±íÃ÷´ó·Ö×ÓÁ¿µÄHA¶ÔÁ£¾¶±ä»¯Ó°Ïì½Ï´ó¡£Í¨¹ý·Å´ó²»Í¬±¶ÊýµÄSEMÕÕÆ¬¿É¿´³öÅäÌåżÁªºóÄÉÃ×Á£·Ö²¼¾ùÔÈ£¬·ÖÉ¢ÐԽϺ㻣¨3£©ÄÉÃ×Á£ÊÍÒ©ËÙÂʺÍÀÛ»ýÊÍÒ©Á¿Ë³ÐòΪPH=4.3£¾PH=5.6£¾PH=7.4£¬ÇÒÔÚÒ»¶¨PH·¶Î§ÄÚËáÐÔԽǿÊÍÒ©ËÙÂʺÍÀÛ¼ÆÊÍ·ÅÁ¿Ô½¸ß£¬¸ßÔØÒ©ÂÊÄÉÃ×Á£ÔÚÏàͬ»·¾³ÏµÄÊÍÒ©ËÙÂʸßÓÚÖС¢µÍÔØÒ©ÂÊÄÉÃ×Á££¬FAżÁªºó¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄÜ»ù±¾ÎÞÓ°Ï죬´ó·Ö×ÓµÄHAżÁªµ½ÄÉÃ×Á£±íÃæºóÊÍÒ©ËÙÂÊÃ÷ÏÔ½µµÍ¡£°ÐÏòPLAÔØÒ©ÄÉÃ×Á£Ä£ÄâÌåÄÚ»·¾³ÊÍÒ©±íÏÖ³öÁ¼ºÃµÄ»ºÊÍЧ¹û£¬ÄâºÏµÄFA/HA-PLAÔØÒ©ÄÉÃ×Á£µÄÊÍÒ©Ä£ÐÍ·Ö±ðΪInIn(1/(1-Q))=0.04633Int-1.03562ºÍ1-Q1/3=-0.01368t+1.04726¡£

google·­Ò룺
The purpose of this experiment: (1) examine the impact on non-target polylactic acid (PLA) drug-loaded nanoparticles preparation of process factors, and prescription process optimization, the preparation of a smaller particle size, drug loading and encapsulation efficiency. high PLA drug-loaded nanoparticles; (2) to explore different reaction conditions for lung targeting ligand folic acid (FA) and the amount of hyaluronic acid (HA) coupling to determine the optimal coupling of the ligand molecule process; (3) examine the impact of different factors on the drug release properties of nanoparticles by simulating the in vivo environment, analysis of the release mechanism and the establishment of appropriate release model, to lay the foundation for the drug in vivo pharmacodynamic studies. Experimental methods: (1) double emulsion (W / O / W) emulsion solvent evaporation method (O / W) Preparation of of oxaliplatin PLA nanoparticles, the gemcitabine PLA nanoparticles and paclitaxel PLA nanoparticles, two preparation methods of nanoparticles particle size and drug loading rate single factor study, filter out the good level orthogonal experiments to optimize the best preparation process. By transmission electron microscopy (TEM) and Zeta potential and laser particle size analyzer nanoparticle morphology and particle size characterization; (2) Over amidation reaction of the FA and HA coupling to the surface of the PLA drug-loaded nanoparticles investigated The reaction conditions on the amount of ligand coupled and find out the best coupling process. Infrared spectroscopy (IR) characterization of ligand coupling, zeta potential and laser particle size analyzer and scanning electron microscope (SEM) coupled ligand nanoparticle size and morphology were characterized; (3) study at different pH values ​​( pH = 4.3 and pH = 5.6 and pH = 7.4), different drug loading rate (9.53%, 17.48% and 26.37%, respectively), and the of coupling ligands on the drug release properties of nanoparticles and simulate the body's internal environment release behavior research, analysis of each stage of the release mechanism, fitting the curve equation model of five common drugs and select the best drug delivery model. Results: (1) single factor and orthogonal design to determine optimal preparation prepared three kinds of drug-loaded nanoparticles, drug loading and encapsulation efficiency obtained in the best preparation conditions of drug-loaded nanoparticles were 26.9%, 66.5%; 27.4%, 67.2% and 30.3%, 73.6%, respectively. Nanoparticle surface is smooth and round, good dispersion, the average particle size of 110nm, 117nm and 125 nm, and the particle size distribution is narrow; (2) changes in the nanoparticle surface molecular groups characterized by infrared spectroscopy (IR), indicating that the HA and FA were successful through the amide key role of coupling to the surface of the nanoparticles. The FA and HA coupling process, under the reaction conditions in the top coupling a coupling amount of FA and HA were 0.0237 ¡Á 10-3mol / g and 0.0178 ¡Á 10 6 mol / g. The particle size analysis showed that the nanoparticles before and after the FA coupled particle size did not change the basic HA (Mr = 300000) the coupled particle size growth from 122.2nm to 131.3nm, indicating that the high molecular weight HA greater impact on particle size change. As can be seen by SEM photographs zoom multiples ligand coupled nanoparticle distribution, good dispersion; (3) nanoparticles release rate and the cumulative amount of drug release order for pH = 4.3 pH = 5.6> pH = 7.4, and the stronger the acidity within a certain pH range higher release rate and cumulative release, high drug loading nanoparticles release rate is higher than in the same environment in low drug loading nanoparticles FA coupling basically no effect on the drug release properties of nanoparticles, macromolecular HA coupled to the surface of the nanoparticles, drug release rate was significantly lower. Exhibit good release effect targeting PLA drug-loaded nanoparticles simulated environment in vivo release fitting FA / HA-PLA model the release of the drug-loaded nanoparticles were ININ (1 / (1-Q)) = 0.04633 Int-1.03562 and 1-Q1 / 3 =-0.01368t +1.04726-.
ÇàÇà×ÓñÆ£¬ÓÆÓÆÎÒÐÄ...
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÑÛœI³ÉÔŠ

гæ (СÓÐÃûÆø)

Ö»°ï×Å¿´Ò»ÏÂÓÐûÓÐÓï·¨´íÎóºÍÐÞ¸Äһϲ»ºÏÊʵĵ¥´Ê»ò¾ä×ӾͿÉÒÔÁË
ÇàÇà×ÓñÆ£¬ÓÆÓÆÎÒÐÄ...
2Â¥2013-04-21 17:26:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

scy0213

Òø³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¹À¼Æ¹»ÇºÓÐÈ˸øÄãŪ  ½¨Ò黹ÊÇ×Ô¼º¶¯ÊÖ·áÒÂ×ãʳµÄºÃ
3Â¥2013-04-21 18:02:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÑÛœI³ÉÔŠ

гæ (СÓÐÃûÆø)

@hookhans

Âé·³Äú°ïÎÒ¿´Ò»ÏÂÄÄЩµØ·½ÓÐÓï·¨´íÎóºÍ²»Ç¡µ±µÄµØ·½°É£¬½ð±ÒÎÒ¿ÉÒÔÔÙ¼Ó£¬Ð»Ð»ÄúÁË
ÇàÇà×ÓñÆ£¬ÓÆÓÆÎÒÐÄ...
4Â¥2013-04-21 20:43:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hookhans

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

Farmer

Ask Rio or huangzx1314, they are more familiar with your work.
where-there-is-a-will-there-is-a-way.
5Â¥2013-04-21 20:55:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÑÛœI³ÉÔŠ

гæ (СÓÐÃûÆø)

@huangzx1314
@Rio2016

Á½Î»ÍâÎĸßÊÖ£¬Âé·³°ï×Å¿´Ò»Ï°ɣ¬Ð»Ð»ÁË
ÇàÇà×ÓñÆ£¬ÓÆÓÆÎÒÐÄ...
6Â¥2013-04-21 21:16:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Rio2016

ľ³æ (СÓÐÃûÆø)

±¾ÎĵÄʵÑéÄ¿µÄ£º£¨1£©¿¼²ìÓ°Ïì·Ç°ÐÏòÐÔ¾ÛÈéËᣨPLA£©ÔØÒ©ÄÉÃ×Á£ÖƱ¸µÄ¹¤ÒÕÒòËØ£¬²¢¶Ô´¦·½½øÐй¤ÒÕÓÅ»¯£¬ÖƱ¸³öÁ£¾¶½ÏС¡¢ÔØÒ©ÂʺͰü·âÂʽϸߵÄPLAÔØÒ©ÄÉÃ×Á££»£¨2£©Ì½Ë÷²»Í¬·´Ó¦Ìõ¼þ¶Ô·Î°ÐÏòÅäÌå·Ö×ÓÒ¶ËᣨFA£©ºÍ͸Ã÷ÖÊËᣨHA£©Å¼ÁªÁ¿µÄÓ°Ï죬ȷ¶¨ÅäÌå·Ö×ÓµÄ×î¼ÑżÁª¹¤ÒÕ£»£¨3£©Í¨¹ýÄ£ÄâÌåÄÚ»·¾³¿¼²ì²»Í¬ÒòËØ¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄܵÄÓ°Ï죬·ÖÎöÊÍÒ©»úÀí²¢½¨Á¢ºÏÊʵÄÊÍÒ©Ä£ÐÍ£¬ÎªÒ©ÎïÔÚÌåÄÚµÄҩЧѧÑо¿µì¶¨»ù´¡¡£
Objectives: £¨1£©investigate the factors affecting the preparation of non-targeting polylactic acid (PLA) drug-loaded nanoparticles£¬optimize the prescription of technology, and prepare the PLA drug-loaded nanoparticles with smaller particle size, higher drug loading ratio and encapsulation efficiency; (2) explore the effect of different reaction conditions on the quantity of coupling between the folic acid (FA) and the hyaluronic acid (HA) which are llung-targeting ligand molecules; (3) investigate the effect of different factors on the drug release properties of nanoparticles by simulating the in vivo environment, analysis the mechanism of drug release and establish the proper model of drug release, laying the foundation for pharmacodynamics study of drug in vivo.


Ä¿µÄ²¿·Ö  ²Î¿¼ÏÂ
ÁÈÁÈÊýÄê¡¢½«¾Í¹ý»î
7Â¥2013-04-21 22:00:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangzx1314

½û³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
ÑÛœI³ÉÔŠ: ½ð±Ò+50, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл£¬ÓõÄÅ®ÅóÓѵĺŠ2013-04-22 08:48:59
ÑÛœI³ÉÔŠ: ½ð±Ò+50, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÔٴθÐл 2013-04-22 09:35:19
²ÉÓõÄʵÑé·½·¨£º£¨1£©²ÉÓø´Èé·¨£¨W/O/W£©ºÍÈ黯ÈܼÁ»Ó·¢·¨£¨O/W£©·Ö±ðÖÆ±¸°ÂɳÀû²¬PLAÄÉÃ×Á£¡¢¼ªÎ÷Ëû±õPLAÄÉÃ×Á£ºÍ×Ïɼ´¼PLAÄÉÃ×Á££¬¶ÔÁ½ÖÖÖÆ±¸·½·¨ÖÐÓ°ÏìÄÉÃ×Á£Á£¾¶ºÍÔØÒ©ÂʵÄÒòËØ½øÐе¥ÒòËØ¿¼²ì£¬É¸Ñ¡³ö½ÏºÃµÄˮƽÉè¼ÆÕý½»ÊµÑ飬ÓÅ»¯µÃµ½×î¼ÑÖÆ±¸¹¤ÒÕ¡£Í¨¹ý͸Éäµç×ÓÏÔ΢¾µ£¨TEM£©ºÍZetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǶÔÄÉÃ×Á£ÐÎòºÍÁ£¾¶½øÐбíÕ÷£»

Experimental methods: (1) both double emulsion (W/O/W) and emulsion solvent evaporation method (O/W) were employed for Preparation of oxaliplatin PLA nanoparticles, the gemcitabine PLA nanoparticles and paclitaxel PLA nanoparticles, the influence factor of two preparation methods on nanoparticles size and drug loading rate were investigated via  single factor investigation, the best orthogonal experiment design achieved, and the preparation process was optimized. nanoparticle morphology and nanoparticle size were characterized through transmission electron microscopy(TEM) and Zeta potential characterization and laser particle size analyzer;

¹ýõ£°·»¯·´Ó¦·Ö±ð½«FAºÍHAżÁªµ½PLAÔØÒ©ÄÉÃ×Á£±íÃæ£¬¿¼²ì²»Í¬·´Ó¦Ìõ¼þ¶ÔÅäÌåżÁªÁ¿µÄÓ°Ïì²¢ÕÒ³ö×î¼ÑżÁª¹¤ÒÕ¡£ºìÍâ¹âÆ×£¨IR£©±íÕ÷ÅäÌåżÁªÇé¿ö£¬Zetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǺÍɨÃèµç×ÓÏÔ΢¾µ£¨SEM£©¶ÔżÁªÅäÌåºóµÄÄÉÃ×Á£Á£¾¶ºÍÐÎò½øÐбíÕ÷£»

FA and HA were coupled on the surface of the PLA drug-loaded nanoparticles through amidation reaction, the optimal amidation process was determined through analysis of the influence of various reaction condition on the amount of ligand coupling. Ligand coupling was characterized though Infrared spectroscopy (IR), nanoparticle size and nanoparticle morphology were characterized through scanning electron microscopy(SEM) and Zeta potential characterization and laser particle size analyzer

½ñÌì±È½ÏÍíÁË£¬Ã÷ÌìÔÙ°ïÄãÕûÒ»ÏÂʣϵģ¬ÎÒÕûÀíµÄ²»Ò»¶¨ÍêÈ«ÕýÈ·£¬½ö¹©Â¥Ö÷²Î¿¼£¬²»¹ýÓиö±ð¾ä×ÓÂ¥Ö÷µÄººÓïÒ²´æÔÚÒ»¶¨µÄÎÊÌ⣬ϣÍûÂ¥Ö÷ÔÙ¶à¶Á¼¸±é£¬ÍêÉÆÒ»Ï¡£
8Â¥2013-04-22 00:06:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yerufeng20

ÈÙÓþ°æÖ÷ (ÎÄѧ̩¶·)

ÐÜ´ó裨ÄϾ©£©

ÎÄÏ׽ܳö¹±Ï×ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÎÄÏ׽ܳö¹±Ï×

ÒýÓûØÌû:
7Â¥: Originally posted by Rio2016 at 2013-04-21 22:00:15
±¾ÎĵÄʵÑéÄ¿µÄ£º£¨1£©¿¼²ìÓ°Ïì·Ç°ÐÏòÐÔ¾ÛÈéËᣨPLA£©ÔØÒ©ÄÉÃ×Á£ÖƱ¸µÄ¹¤ÒÕÒòËØ£¬²¢¶Ô´¦·½½øÐй¤ÒÕÓÅ»¯£¬ÖƱ¸³öÁ£¾¶½ÏС¡¢ÔØÒ©ÂʺͰü·âÂʽϸߵÄPLAÔØÒ©ÄÉÃ×Á££»£¨2£©Ì½Ë÷²»Í¬·´Ó¦Ìõ¼þ¶Ô·Î°ÐÏòÅäÌå·Ö×ÓÒ¶ËᣨFA£©ºÍ͸ ...

ллÁ˹þ£¬Ó¢Óï²î£¬¸Ð¾õÄãÃÇ·­ÒëµÄÕæºÃ
ØùÒÐΣ¥·çϸϸ£¬Íû¼«´º³î£¬÷ö÷öÉúÌì¼Ê¡£²ÝÉ«Ñ̹â²ÐÕÕÀÎÞÑÔË­»áƾÀ»Òâ¡£Äâ°ÑÊè¿ñͼһ×í¡£¶Ô¾Æµ±¸è£¬Ç¿ÀÖ»¹ÎÞζ¡£Ò´ø½¥¿íÖÕ²»»Ú£¬ÎªÒÁÏûµÃÈËã¾ã²¡£
9Â¥2013-04-22 08:44:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yerufeng20

ÈÙÓþ°æÖ÷ (ÎÄѧ̩¶·)

ÐÜ´ó裨ÄϾ©£©

ÎÄÏ׽ܳö¹±Ï×ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÎÄÏ׽ܳö¹±Ï×

ÒýÓûØÌû:
8Â¥: Originally posted by huangzx1314 at 2013-04-22 00:06:31
²ÉÓõÄʵÑé·½·¨£º£¨1£©²ÉÓø´Èé·¨£¨W/O/W£©ºÍÈ黯ÈܼÁ»Ó·¢·¨£¨O/W£©·Ö±ðÖÆ±¸°ÂɳÀû²¬PLAÄÉÃ×Á£¡¢¼ªÎ÷Ëû±õPLAÄÉÃ×Á£ºÍ×Ïɼ´¼PLAÄÉÃ×Á££¬¶ÔÁ½ÖÖÖÆ±¸·½·¨ÖÐÓ°ÏìÄÉÃ×Á£Á£¾¶ºÍÔØÒ©ÂʵÄÒòËØ½øÐе¥ÒòËØ¿¼²ì£¬É¸Ñ¡³ö½ÏºÃµÄË® ...

ллÁ˰¡£¬ÎÒººÓïûѧºÃ£¬Ó¢ÓïѧµÄ¾Í¸ü²îÁË£¬°¦£¬ºÜÆæ¹ÖµÄ£¬¶ÔÓïÑÔû¸Ð¾õ£¬Âé·³ÄúÔÙ¸øÎÒ¿´¿´Ê£Ïµİɣ¬EPIÖ»ÄܸøÒ»¸öÈËÂð£¿Äú°ïÎÒ·­ÒëµÄ¶à£¬ºÇºÇ£¬ÏȸøÄú°É
ØùÒÐΣ¥·çϸϸ£¬Íû¼«´º³î£¬÷ö÷öÉúÌì¼Ê¡£²ÝÉ«Ñ̹â²ÐÕÕÀÎÞÑÔË­»áƾÀ»Òâ¡£Äâ°ÑÊè¿ñͼһ×í¡£¶Ô¾Æµ±¸è£¬Ç¿ÀÖ»¹ÎÞζ¡£Ò´ø½¥¿íÖÕ²»»Ú£¬ÎªÒÁÏûµÃÈËã¾ã²¡£
10Â¥2013-04-22 08:46:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÑÛœI³ÉÔŠ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 8rmuugja8q 2026-02-22 8/400 2026-02-23 12:22 by alian_214
[»ù½ðÉêÇë] ÌåÖÆÄÚ³¤±²ËµÌåÖÆÄÚ¾ø´ó²¿·ÖÒ»±²×ÓÔڵײ㣬ÈçͬÄãÃÇÒ»Ñù´ó²¿·ÖÆÕͨ½ÌʦæÇÒÊÕÈëµÍ +10 ˲ϢÓîÖæ 2026-02-20 13/650 2026-02-23 11:23 by holypower
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 09:29 by w4l55oybr1
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 usprnugpzw 2026-02-21 11/550 2026-02-23 09:24 by w4l55oybr1
[½Ìʦ֮¼Ò] ΪʲôÖйú´óѧ¹¤¿Æ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿ +5 »¶ÀÖËÌÒ¶Ýè 2026-02-21 8/400 2026-02-23 09:19 by »¶ÀÖËÌÒ¶Ýè
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 w89i99eaeh 2026-02-22 5/250 2026-02-23 08:04 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 6/300 2026-02-23 07:59 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +6 3dfhjxgsh7 2026-02-22 9/450 2026-02-23 07:49 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 4/200 2026-02-23 06:46 by jsjzfl
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 5/250 2026-02-23 06:29 by w4l55oybr1
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 06:24 by w4l55oybr1
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 3dfhjxgsh7 2026-02-22 6/300 2026-02-23 02:04 by 5jlh3qtdvx
[½Ìʦ֮¼Ò] °æÃæ·Ñ¸Ã½»Âð +7 Æ»¹ûÔÚÄÄÀï 2026-02-22 8/400 2026-02-22 22:37 by otani
[»ù½ðÉêÇë] ÃæÉÏ¿ÉÒÔ³¬¹ý30Ò³°É£¿ +4 °¢À­¹±aragon 2026-02-22 4/200 2026-02-22 21:22 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 3dfhjxgsh7 2026-02-22 4/200 2026-02-22 16:52 by khieu8v8m0
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-22 3/150 2026-02-22 16:37 by khieu8v8m0
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-21 4/200 2026-02-22 16:27 by khieu8v8m0
[»ù½ðÉêÇë] ¡°ÈËÎÄÉç¿Æ¶øÂÛ£¬Ðí¶àѧÊõÑо¿»¹Ã»ÓдﵽÃñ¹úʱÆÚµÄˮƽ¡± +4 ËÕ¶«ÆÂ¶þÊÀ 2026-02-18 5/250 2026-02-22 16:07 by liangep1573
[»ù½ðÉêÇë] ʲôÊÇÈËÒ»Éú×îÖØÒªµÄ£¿ +4 ˲ϢÓîÖæ 2026-02-21 4/200 2026-02-22 11:44 by huagongfeihu
[»ù½ðÉêÇë] ½ñÄê´ºÍíÓм¸¸ö½ÚÄ¿ºÜ²»´í£¬µãÔÞ£¡ +11 ˲ϢÓîÖæ 2026-02-16 12/600 2026-02-21 21:14 by lq493392203
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û